Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPACHINOS-2: Caffeine for Postoperative Delirium
NCT05574400Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Feb 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of caffeine in postoperative delirium (POD), Post-operative cognitive dysfunction (POCD) and Mild Cognitive Impairment (MCI) (3 arms), sponsored by University of Michigan. Primary endpoint: Incidence of Delirium. Started Feb 2023; status: completed.
02
Drugs
caffeine
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT05574400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05574400.